A Novel Fibrinogen Variant: Dysfibrinogenemia Associated With Gamma Asp185asn Substitution

Na Zhou,Peipei Xu,Min Zhou,Yong Xu,Ping Li,Bin Chen,Jian Ouyang,Rongfu Zhou

DOI: https://doi.org/10.1007/s11239-017-1496-y

2017-01-01

Journal of Thrombosis and Thrombolysis

Abstract:To identify the pathogenesis of a Chinese woman diagnosed with dysfibrinogenemia. A patient from Nanjing presented with a low plasma concentration of fibrinogen and a normal level of antigen of fibrinogen. This abnormality was also detected in her son. To detect whether the genetic mutation was responsible for the dysfibrinogenemia, genomic DNA was extracted and amplified by polymerase chain reaction, and DNA sequencing was performed on the purified PCR products. Restriction fragment length polymorphism (RFLP), molecular modeling and homologous sequences alignment were performed. Two heterozygous missense variants, AaArg16His and.Asp185Asn, were discovered in the proband. Only the former was detected in her son. AaArg16His had been reported by other teams, and.Asp185Asn was identified first in our study as a novel variant. RFLP was performed and indicated that the novel failed to be found in normal subjects. Furthermore, it was suggested to be responsible for dysfibrinogenemia depending on the molecular modeling and homologous sequence alignment. The heterozygous AaArg16His and.Asp185Asn identified in the study probably underlie the dysfibrinogenemia in this pedigree, with the latter being identified for the first time.